Julie Maltzman has joined Genentech as Group Medical Director & Global Development Team Leader, Cancer Immunotherapy Solid Tumor Combination Studies. Dr. Maltzman joins Genentech from Nektar where she served as Vice President, Clinical Development. In addition to a MD from the University of Colorado, Dr. Maltzman has held positions of increasing related responsibility at GSK, Morphotek, Inc., and Gilead.
The search was successfully led by Tamir Halaban at Westwood & Wilshire.
At Westwood & Wilshire, we recognize that people are an organization's top asset. We are passionate about delivering premier talent to the world’s most innovative companies. We are particularly focused on companies ranging from VC-backed start-ups to mid-sized commercial entities and our assignments range from C-Suite to mid-management. Based in Los Angeles, California with additional offices in Silicon Valley, we serve our clients on a local, national and global basis.
Westwood & Wilshire, LLC
Offices in Los Angeles, Silicon Valley, Seattle, and Scottsdale
© Westwood & Wilshire LLC. All Rights Reserved.